Issue 2 of VRWorldTech Magazine is focusing on healthcare. These are the companies coming under the spotlight
➨ Training and treatment are the focuses of VRWorldTech Magazine’s healthcare spotlight
➨ Oxford Medical Simulation, AppliedVR, Oxford VR, XRHealth and Precision OR will feature
➨ Sign up to the weekly VRWorldTech newsletter to receive digital magazine
Immersive technology’s potential in the training of medical professionals and the treatment of complex health issues is fast becoming clear, as several products and services already on the market are demonstrating.
Oxford Medical Simulation (OMS), which develops training scenarios for healthcare professionals, is being utilised at Oxford University and the University of New England, among others, and the London- and Boston-based company has just released OMS Interprofessional, a multiplayer VR simulation platform.
One immersive tech company cognizant of the challenges inherent in training medical professionals is Vancouver-based Precision OS, which proved the value of its tech with the receipt of accreditation from a professional development provider of the Royal College of Physicians and Surgeons in Canada for its orthopaedic surgery VR training platform.
In treatment, London-based Oxford VR (OVR) is developing leading-edge VR-enabled therapy, building on almost two decades of clinical research by Daniel Freeman, professor of clinical psychology at Oxford University, and chief clinical officer and co-founder of the spinoff.
OVR’s therapies, which it’s testing through the Yes I Can initiative in Asia in partnership with insurance company AXA and the Chinese University of Hong Kong, as well as with the National Mental Health Innovation Center in the US and the NHS in the UK, are able to treat a range of mental health conditions.
Los Angeles-headquartered AppliedVR is using VR to develop treatments for medical issues such as pain by, first and foremost, building a solid foundation of evidence demonstrating the efficacy of its immersive tech.
The National Institute on Drug Abuse recently awarded more than $2.9 million in funding to AppliedVR to support clinical trials on VR as a therapeutic alternative for acute and chronic pain. The grants will enable AppliedVR to advance two clinical trial programmes with Geisinger and Cleveland Clinic, studying two of its platforms, RelieVRx and EaseVRx.
Boston-based XRHealth, the developer of a VR and AR telehealth platform of immersive, therapeutic applications that address a variety of neuro-cognitive, emotional and physical symptoms, is working with hospitals, rehab centres and insurance companies.
Last year, the company opened its VRHealth platform to third-party developers. First movers included Healing HealthCare Systems and VirZOOM. The latest to be announced, Healium by StoryUP, developed a biometrically-controlled solution that is designed to reduce anxiety and stress, allowing users to see their feelings empower virtual worlds via a smartwatch or EEG device.